PRESS RELEASE published on 02/06/2024 at 10:10, 2 years 4 months ago TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology Series A Financing TVM Capital Life Science Vektor Medical Arrhythmia Care AI-based Analysis
PRESS RELEASE published on 01/31/2024 at 10:00, 2 years 4 months ago TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes Investment TVM Capital Life Science Myosotis GmbH Innovative App Elderly Care
PRESS RELEASE published on 07/20/2023 at 14:00, 2 years 11 months ago Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
PRESS RELEASE published on 03/17/2023 at 14:00, 3 years 3 months ago TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
PRESS RELEASE published on 02/23/2023 at 14:00, 3 years 3 months ago TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
PRESS RELEASE published on 02/08/2023 at 14:00, 3 years 4 months ago TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
PRESS RELEASE published on 02/01/2023 at 14:00, 3 years 4 months ago TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
Published on 06/20/2026 at 01:00, 1 day 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 23 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 7 hours 2 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 27 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 8 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 10 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 10 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 10 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026